221 related articles for article (PubMed ID: 24809782)
1. SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.
Turato C; Vitale A; Fasolato S; Ruvoletto M; Terrin L; Quarta S; Ramirez Morales R; Biasiolo A; Zanus G; Zali N; Tan PS; Hoshida Y; Gatta A; Cillo U; Pontisso P
Br J Cancer; 2014 May; 110(11):2708-15. PubMed ID: 24809782
[TBL] [Abstract][Full Text] [Related]
2. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer.
Terrin L; Agostini M; Ruvoletto M; Martini A; Pucciarelli S; Bedin C; Nitti D; Pontisso P
Oncotarget; 2017 Feb; 8(9):15732-15743. PubMed ID: 28178650
[TBL] [Abstract][Full Text] [Related]
3. SERPINB3 modulates TGF-beta expression in chronic liver disease.
Turato C; Calabrese F; Biasiolo A; Quarta S; Ruvoletto M; Tono N; Paccagnella D; Fassina G; Merkel C; Harrison TJ; Gatta A; Pontisso P
Lab Invest; 2010 Jul; 90(7):1016-23. PubMed ID: 20212457
[TBL] [Abstract][Full Text] [Related]
4. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
[TBL] [Abstract][Full Text] [Related]
6. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
8. Role of SERPINB3 in hepatocellular carcinoma.
Pontisso P
Ann Hepatol; 2014; 13(6):722-7. PubMed ID: 25332258
[TBL] [Abstract][Full Text] [Related]
9. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
[TBL] [Abstract][Full Text] [Related]
10. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and SerpinB3 in hepatocellular carcinoma.
Turato C; Simonato D; Quarta S; Gatta A; Pontisso P
Life Sci; 2014 Mar; 100(1):9-17. PubMed ID: 24496037
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
16. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.
Turato C; Cannito S; Simonato D; Villano G; Morello E; Terrin L; Quarta S; Biasiolo A; Ruvoletto M; Martini A; Fasolato S; Zanus G; Cillo U; Gatta A; Parola M; Pontisso P
Sci Rep; 2015 Dec; 5():17701. PubMed ID: 26634820
[TBL] [Abstract][Full Text] [Related]
17. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
18. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
Xia H; Ooi LL; Hui KM
PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
[TBL] [Abstract][Full Text] [Related]
19. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
[TBL] [Abstract][Full Text] [Related]
20. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
Dig Dis Sci; 2013 Jul; 58(7):1916-22. PubMed ID: 23456506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
